Regulated apoptosis

Details Regulated apoptosis Regulated apoptosis

2010-01-07

2011-12-27

Joike, Michele K (Department: 1636)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C435S320100, C435S325000

Reexamination Certificate

active

08084596

ABSTRACT:
We have developed a general procedure for the regulated (inducible) dimerization or oligomerization of intracellular proteins and disclose methods and materials for using that procedure to regulatably initiate cell-specific apoptosis (programmed cell death) in genetically engineered cells.

REFERENCES:
patent: 5171671 (1992-12-01), Evans et al.
patent: 5830462 (1998-11-01), Crabtree et al.
patent: 5834266 (1998-11-01), Crabtree et al.
patent: 5869337 (1999-02-01), Crabtree et al.
patent: 5871753 (1999-02-01), Crabtree et al.
patent: 5928868 (1999-07-01), Liu et al.
patent: 5994313 (1999-11-01), Crabtree et al.
patent: 6011018 (2000-01-01), Crabtree et al.
patent: 6043082 (2000-03-01), Crabtree et al.
patent: 6046047 (2000-04-01), Crabtree et al.
patent: 6054436 (2000-04-01), Crabtree et al.
patent: 6063625 (2000-05-01), Crabtree et al.
patent: 6117680 (2000-09-01), Natesan et al.
patent: 6140120 (2000-10-01), Crabtree et al.
patent: 6165787 (2000-12-01), Crabtree et al.
patent: 6316418 (2001-11-01), Crabtree et al.
patent: 6891021 (2005-05-01), Crabtree et al.
patent: 6972193 (2005-12-01), Crabtree et al.
patent: 2034220 (1991-07-01), None
patent: 0 325 849 (1989-08-01), None
patent: 0 594 847 (1994-05-01), None
patent: WO 90/15815 (1990-12-01), None
patent: WO 92/01052 (1992-01-01), None
patent: WO 93/23550 (1993-11-01), None
patent: WO 93/25533 (1993-12-01), None
patent: WO 95/34646 (1995-12-01), None
Freiberg et al. Specific triggering of the Fas signal transduction pathway in normal human keratinocytes. J Biol Chem. Dec. 6, 1996;271(49):31666-9.
Alberg, D.G and Schreiber, S.L. Structure-Based Design of a Cyclophilin-Calcineurin Bridging Ligand.Science262, 248-250 (1993).
Albers, M.W. et al. An FKBP-Rapamycin Sensitive, Cyclin-Dependent Kinase Activity That Correlates with the FKBP Rapamycin-Induced G1 Arrest Point in MG-63 Cells.Annals of N. Y. Acad. Sci. 696, 54-62 (1993).
Albers, M.W. et al. FKBP, Thought to be Identical to PKCI-2, Does Not Inhibit Protein KinaseC. BioMed. Chem. Lett. 1, 205-210 (1991).
Albers, M.W. et al. Relationship of FKBP to PKCI-1.Nature351, 527 (1991).
Albers, M.W. et al. Substrate Specificity for the Human Rotamase FKBP: A View of FK506 and Rapamycin as Leucine (twisted amide)-Proline Mimics.J. Org. Chem. 55, 4984-4986 (1990).
Andrus, M.B. and Schreiber, S.L. Structure-Based Design of an Acyclic Ligand That Bridges FKBP12 and Calcineurin.J. Am. Chem. Soc. 115, 10420-10421 (1993).
Arvidsson et al, Cell Growth and Differentiation, vol. 3; pp. 881-887 (abstract) (1992).
Becker et al., “Fusion of adenovirus E1A to the glucocorticoid receptor by high-resolution deletion cloning creates a hormonally inducible viral transactivator,” Mol. Cell. Biol., vol. 9, pp. 3878-3887 (1989).
Ben-Levy, R. et al. A oncogenic point mutation confers High Affinity Ligand Binding to the neu Receptor.J. Biol. Chem. 267, 1 7304-1 731 3 (1992).
Bergmann, K.E. et al., “Bivalent ligands as probes of estrogen receptor action”, Journal of Steroid Biochemistry and Molecular Biology, vol. 49(2-3), pp. 139-152 (1994).
Bergsma, D.J. et al. The Cyclophilin Multigene Family of Peptidyl-Prolyl Isomerases.J. Biol. Chem. 266, 23204-23214 (1991).
Bernard, O. et al. High-affinity Interleukin-2 Binding by an Oncogenic Hybrid Interleukin-2 Epidermal Growth Factor Receptor Molecule.PNAS84, 2125-2129 (1987).
Bierer, B. E. et al., Probing immunosuppressant action with a nonnatural immunophilin ligand. Science, vol. 250(4980), pp. 556-559 (1990).
Bierer, B.E. et al. Mechanisms of Immunosuppression by FK506: Preservation of T Cell Transmembrane Signal Transduction.Transplantation49, 1168-1202 (1990).
Bierer, B.E. et al. The Effect of the Immunosuppressant FK506 on Alternate Pathways of T Cell Activation.Eur. J. Immunol. 21, 439-445 (1991).
Bierer, B.E. et al. Two Distinct Signal Transmission Pathways in T Lymphocytes are Inhibited by Complexes Formed Between an Immunophilin and Either FK506 or Rapamycin.PNAS87, 9231-9235 (Dec. 1990).
Bonnerot, C. et al. Role of associated γ-chain in Tyrosine Kinase Activation via Murine FcRIII.Embo J. 11, 2747-2757 (1992).
Bram, R.J. et al. Identification of the Immunophilins Capable of Mediating Inhibition of Signal Transduction by Cyclosporin A and FK506: Roles of Calcineurin Binding and Cellular Location.Mol. Cell. Biol. 13, 4760-4769 (Aug. 1993).
Byrn, R.A. et al. Biological Properties of a CD4 Immunoadhesin. Nature 344, 667-670 (Apr. 12, 1990).
Cantley, L.C. et al. Oncogenes and signal transduction.Cell64, 281-302 (Jan. 25, 1991).
Chan, A.C. et al. The ζChain is associated with a Tyrosine Kinase and upon T-Cell Antigen Receptor Stimulation Associates with ZAP-70, a 70-kDa Tyrosine Phosphoprotein.PNAS88, 9166-9170 (Oct. 1991).
Chung, J. et al. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases.Cell69, 1227-1236 (Jun. 26, 1992).
Clark, M.R. et al. The B Cell Antigen Receptor Complex: Association of Ig-α, and Ig-β with Distinct Cytoplasmic Effectors.Science258, 123-126 (Oct. 2, 1992).
Clipstone, N.A. et al. Calcineurin: Molecular analysis of its interaction with drug-immunophilin complexes and its role in the regulation of NF-AT.J. Cell. Biochem. Suppl. 0 (18B) 274, Abstract #1410 (1994).
Crabtree, G. R. IL-2 receptor in the pathogenesis of human lymphoma. Abstract of NIH Grant 5R01CA039612-03 (1987).
Crabtree, G. R. Pathways of T lymphocyte activation. Abstract of NIH Grant 2R01CA039612-07 (1991).
Crabtree, G.R. “Pathways of T lymphocyte activation,” Abstract of NIH Grant R01CA39612 (1988).
DiLella, A.G. et al. Chromosomal Band Assignments of the Genes Encoding Human FKBP12 and FKBP13.Biochem. Biophys. Res. Commun. 189, 819-823 (Dec. 15, 1992).
Donald, D.K. et al. C10 N-Acyl Modified FK-506: A Possible Hybrid Analogue of the Transition State of Petidyl-Prolyl Cis-Trans Isomerization.Tetrahedron Letters31, 1375-1378 (1991).
Durand, D.B et al. Characterization of Antigen Receptor Response Elements within the Interleukin-2 Enhancer.Mol. Cell. Biol. 8, 1715-1724 (Apr. 1988).
Eberle, M.K. and Nuninger, F. Synthesis of the Main Metabolite (OL-17) of Cyclosporin A.J. Org. Chem. 57, 2689-2691 (1992).
Edalji, R. et al. High-Level Expression of Recombinant Human FK-Binding Protein from a Fusion Precursor.J. Prot. Chem. 11, 213-223 (1992).
Eiseman, E. and Bolen, J.B. Signal Transduction by the Cytoplasmic Domains of FcεRI-y and TCR0j-y in Rat Basophilic Leukemia Cells.J. Biol. Chem. 267, 21027-21032 (Oct. 15, 1992).
Emmel, E.A. et al. Cyclosporin A Specifically Inhibits Function of Nuclear Proteins Involved in T-Cell Activation.Science246, 1617-1620 (Dec. 22, 1989).
Engel, I. et al. High-Efficiency Expression and Solubization of Functional T-Cell antigen Receptor Heterodimers.Science256, 1318-1321 (May 29, 1992).
European Search Report (EP 07 01 7076) dated Aug. 28, 2008 (3 pages).
Evans et al. Mechanistic study of the rhodium(I)-catalyzed hydroboration reaction. J. Am. Chem. Soc. 114, 6679-6685 (1992).
Evans, D.A. et al. Mechanistic Study of the Rhodium(I)- and Iridium(I)- Catalyzed Hydroboration Reactions: Scope and Synthetic Applications.J. Am. Chem. Soc. 114, 6671-6679 (1992).
Farrar et al., “Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization,”Letters to Nature, 383:178-181 (1996).
Fields, S. & Song, O-k.. A Novel Genetic System to Detect Protein-Protein Interactions.Nature340, 245-246 (Jul. 20, 1989).
Fischer, G. et al. Mip protein ofLegionella pneumophilaexhibits peptidyl-prolyl-cis/trans isomerase (Pplase) activity.Mol. Microbiol. 6, 1375-1383 (1992).
Fisher, M.J. et al. On the Remarkable Propensity for Carbon-Carbon Bond Cleavage Reactions in the C8-C10 Region of Fk-506.J. Org. Chem. 56, 2900-2907 (1991).
Flanagan, W.M. et al. Intracellular signal transmission: a novel role for the prolyl isomerases.J. Cell. Biochem. Suppl. 0 (16 Part A) 61, Abstract #B005 (1992).
Flanagan, W.M. et al. Nuclear Association of a T-Cell Transcription Factor Blocked by a Tyrosine Factor Blocked by FK-506 and C

Affiliated with

Also associated with

Rating

Regulated apoptosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Regulated apoptosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regulated apoptosis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4309359